Saturday 29 October 2022

Week 377 Review - Flat as a pancake but thankfully not a new record low

A pretty flat week and happy to say that we didn't drop to a new record low, but the deficit between cost and value narrowed by a tiny £381 to £110,442 and portfolio value crept up to £70,146.

There were no big fallers this week.

NUM:Numis Corp made back some of the recent huge losses and climbed 5%, but they are still 33% down and my new "sell at 15% loss" rule failed to kick in as it sneaked down when the whole market was tanking but failed to recover when the other shares did. Basically I was too slow, and now it's too late so I have to hope they recover.

IGG:IG Group and PLUS:Plus500 tend to follow similar fortunes, and this week both went up by 6%. However, IGG is down by 10% whereas PLUS is up by 13%. Both have paid excellent dividends.

AJB:AJ Bell wins Share of the Week with an impressive 10% rise into profit. It's only 3% profit, but any share that goes positive these days is a gem.




It's been pretty flat for a while now. Absolutely no sign of any upward momentum.




Back above the trend line - but for how long?

Here's the ISA and shares portfolio after week 13 of year 8.




Weekly Change
Cash £56.42

+£0
Portfolio cost £82,003.25
+£0
Portfolio sell value (bid price-commission) £28,830.96 (-64.8%) +£27.88
Potential profits £0
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.02
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£334.37 (-9.0%) +£27.86
Total Dividends £11,768.92
+£0
Total Interest £0.02
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £442.91
(12.0%) -£1.18
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

Possibly the flattest week ever






As with the overall chart, we've sneaked above the trend line, but not enough to move it.

The SIPP looks like this after week 361 overall and week 49 of year 7.




Weekly Change
Cash £149.19
+£55.64
Portfolio cost £96,510.40
+£189.95
Portfolio sell value
(bid price - commission)
£40,438.55 (-58.1%) +£353.35
Potential profits £164.21
+£98.59
Yr 7 Dividends £10,911.87
+£103.10
Yr 7 Interest £0.01
+£0
Yr 7 Profit from sales -£3,290.88
+£0
Yr 7 projected avg monthly profit £659.55 (13.9%) -£4.43
Total Dividends £14,116.26
+£103.10
Total Interest £0.21
+£0
Total Profit from sales £20,433.75
+£0
Average monthly cash profit £402.90 (8.5%) +£0.12
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 59% +0%

I received a dividend of £103 from CAML:Central Asia Metals and it reminded me why I like them so much. Given they now have no debt, and assuming they don't find a new mine to buy, hopefully we'll get even more. I will definitely be using some of my £2,000 pension transfer to buy some more next week as there's nothing takes my fancy in the magic formula contenders.

I received a tax rebate in my AJ Bell SIPP so I added another £50 so I could buy 1,009 shares in OPTI:Optibiotix at 17.84p costing £189.96. I want to get enough so that when I sell the ones in my share account and the ones I bought with JLP:Jubilee Metals proceeds, I will still have over 200,000 left. It means I'll need to spend £1,000 of my pension transfer buying some more. I had a wee wobble a few weeks ago, but am back feeling optimistic as the business model is still sound, it's just taking bloody ages.

Potential profits increased by £98 thanks to AJB:AJ Bell and PLUS:Plus500 increasing well, and the portfolio value went up £353 which unfortunately doesn't recover last week's losses. I seem to gain by hundreds but lose by thousands.




Very flat




Back above the tend line

The trading account looks like this after week 327 overall and week 15 of year 7.




Weekly Change
Cash £0.10
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £671.20 (-63.7%) +£0
Potential profits £0.00
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£20.72 (-13.4%) +£1.48
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.85 (1.8%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)

Absolutely no change whatsoever






Hmm - some danger that the trend line will overtake us soon unless some stonking news from OPTI:Optibiotix gives us a lift, or TALY:Tally re-floats, although that might cause a plummet.

Looking forward to getting my £2,000 pension transfer next week. I haven't got the energy to find two new magic formula shares, especially after the dismal performance of the last one, so sticking with the devils I know and splitting it between OPTI:Optibiotix and CAML:Central Asia Metals, both of which are very cheap at the moment. Historically the price drops every time I buy them - which is a tad frustrating. CAML has been very good to me, making £4,769 profits from sales and giving £2,150 in dividends. The only time I sold any OPTI was in my trading account where I made £65, but they have given me the equivalent of £20,846 in dividends with the PBX:Probiotix share distribution. It's just a shame I'm down £79,456 on my investment!

One day...

Sunday 23 October 2022

Week 376 Review - Yet another new low as Probiotix tanks

This was nearly a positive week, with most shares flat and OPTI:Optibiotix gaining 0.5p, but a 3p drop in PBX:Probiotix following one large sale completely destroyed the week and sent the portfolio to a new record low. The deficit between cost and value widened by £2,185 to £110,803 and portfolio value dropped to £69,519. I'm really fed up.

The 3p drop in PBX:Probiotix Health wiped out 15% of one of my biggest holdings and took it from 5% in profit to 10% loss. I know these will tank in January when the embargo is lifted and people can sell them. I bought some in anticipation of good news that would lift the price before Christmas so I could sell them for a profit before January then buy a load at bargain price with the proceeds when they tank. There has been no news and there is no sign that there will be, so my plan is falling apart.

NUM:Numis Corp dropped 9% after a 12% drop last week, so clearly my new method for choosing magic formula shares is even worse than the last one. I'm beginning to think I have a curse!

Share of the Week is CEY:Centamin which climbed 5% after really good results. I can't believe these are still trading so low when they have an utterly gigantic pile of cash and no debt. I really hope they dish out a massive special dividend as my holding is still 24% down, although with 8% dividends I'd only lose 16% if I sold them now.




Very bad.




Last week the trend line crossed below the value line. Clearly the value line was uncomfortable with this situation and dropped back to meet the trend line.

Here's the ISA and shares portfolio after week 12 of year 8.




Weekly Change
Cash £56.42

+£0
Portfolio cost £82,003.25
+£0
Portfolio sell value (bid price-commission) £28,803.08 (-64.9%) -£972.16
Potential profits £0
-£471.51
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.02
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£362.23 (-9.8%) +£32.93
Total Dividends £11,768.92
+£0
Total Interest £0.02
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £444.09
(12.0%) -£1.18
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

All potential profits wiped out with the drop in PBX:Probiotix, and almost £1,000 wiped off the portfolio value. All bad.




Record low




Back on the downward trend line

The SIPP looks like this after week 360 overall and week 48 of year 7.




Weekly Change
Cash £93.55
+£36.24
Portfolio cost £96,320.45
+£0
Portfolio sell value
(bid price - commission)
£39,895.25 (-58.6%) -£1,225.98
Potential profits £65.62
-£502.38
Yr 7 Dividends £10,808.77
+£36.24
Yr 7 Interest £0.01
+£0
Yr 7 Profit from sales -£3,290.88
+£0
Yr 7 projected avg monthly profit £663.98 (14.0%) -£10.79
Total Dividends £14,013.16
+£36.24
Total Interest £0.21
+£0
Total Profit from sales £20,433.75
+£0
Average monthly cash profit £402.78 (8.5%) -£0.69
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 59% +0%

I got a £36 dividend from IGG:IG Group which also increased cash, portfolio value dropped by over £1,000 and all PBX:Probiotix potential profits were wiped out, leaving just PLUS:Plus500 in profit.




Looks like it's about equal worst in last 12 months, but cost has gone up by over £10k since we were last at this level




As with the other accounts, we're firmly back on the trend line

The trading account looks like this after week 326 overall and week 14 of year 7.




Weekly Change
Cash £0.10
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £671.20 (-63.7%) +£12.35
Potential profits £0.00
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£22.20 (-14.4%) +£1.71
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.86 (1.9%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)

OPTI:Optibiotix went up by 0.5p which gave a £12 increase in value. Something to celebrate this week!




Still in desperate trouble




It's so nice to see a positive trend line and to still be above it.

Let's see how much lower the portfolio can go next week!

Sunday 16 October 2022

Week 375 Review - Another flat week but bad enough to drop to new record low

Many shares dropped this week, but the losses were limited to £214, making it a flat week. The problem is that the losses were more than the gains from last week, so taking the deficit between cost and value to a record high of £108,617 and dropping portfolio value to £71,555 despite my monthly £130 savings going in.

The biggest loser was NUM:Numis Corp which dropped 12% to go 19% down. So much for my new rule that I sell anything that goes 15% down. The shocking state of the market at the moment makes me unwilling to sell anything, as it's not a problem with the company but rather the massive volatility in the market as the British economy is systematically destroyed from within.

AJB:AJ Bell dropped 5% after last week's 10% rise, so is now 10% down

CEY:Centamin also dropped 5% despite great news on the near completion of their solar power plant.

SBTX:SkinBioTherapeutics wins Share of the Week as it almost halved the losses I would have shown without it, and it was the only one to climb by 5%.




It's been flat throughout one of the most turbulent periods in decades.




Appropriate to see that the trend line has gone below the chart line, rather than the chart line going above the trend line.

Here's the ISA and shares portfolio after week 11 of year 8.




Weekly Change
Cash £56.42

-£3.75
Portfolio cost £82,003.25
+£0
Portfolio sell value (bid price-commission) £29,775.24 (-63.7%) +£82.75
Potential profits £471.51
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.02
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£395.16 (-10.7%) +£39.52
Total Dividends £11,768.92
+£0
Total Interest £0.02
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £445.27
(12.0%) -£1.19
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

Cash was down due to fees, and amazingly this portfolio was slightly up by £82. Long term performance still above target thanks to PBX:Probiotix dividend, but imminent demise of DDDD:4D Pharma will negate that. Nice to know that it's inevitably going to get much worse than it is even now.




Very flat




Same story as the combined chart, with trend line crossing below the chart line

The SIPP looks like this after week 359 overall and week 47 of year 7.




Weekly Change
Cash £57.31
-£19.85
Portfolio cost £96,320.45
+£123.90
Portfolio sell value
(bid price - commission)
£41,121.23 (-57.3%) -£296.82
Potential profits £568.00
-£17.01
Yr 7 Dividends £10,772.53
+£0
Yr 7 Interest £0.01
+£0
Yr 7 Profit from sales -£3,290.88
+£0
Yr 7 projected avg monthly profit £674.77 (14.2%) -£14.66
Total Dividends £13,976.92
+£0
Total Interest £0.21
+£0
Total Profit from sales £20,433.75
+£0
Average monthly cash profit £403.47 (8.5%) -£1.12
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 59% +0%

Cash dropped £19 thanks to monthly charges plus a few AJ Bell account charges I'd forgotten to subtract over the last few months. Portfolio cost went up £123 as I bought 54 shares in EMG:Man Group at 226.651p, but portfolio value dropped £286 thanks to most of my magic formula shares falling. Potential profits only slipped £17 thanks to a small drop in PLUS:Plus500.




Ditto the charts above




Also ditto the charts above

The trading account looks like this after week 325 overall and week 13 of year 7.




Weekly Change
Cash £0.10
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £658.85 (-64.4%) +£0
Potential profits £0.00
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£23.91 (-15.5%) +£1.99
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.87 (1.9%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)

Absolutely nothing changed





The trend line it pointing upwards!!

I despair of ever again getting that feeling of great joy when brilliant news lands and a share price rockets. For over a year the news has either been dire or any good news has done nothing for the share price. I'm completely fed up, and way worse off than I would have been putting my money under the mattress. It's a good job I enjoy documenting the numbers, as this whole exercise has been 7 years of wasted time so far.

Sunday 9 October 2022

Week 374 Review - One of the flattest weeks but at least not a down week

A very flat week with few changes across most of the portfolio. The deficit between cost and value improved by a tiny £158 to £108,403 and portfolio value is now £71,645, so still desperately bad.

There were no big fallers this week.

PLUS:Plus500 climbed 7% and is now 10% up and is one of my few successful shares. There's a dividend due soon too.

AJB:AJ Bell wins Share of the Week for climbing an impressive 10% and is now only 5% down.




I think that's what you call scraping along the bottom of the barrel, assuming there's not even further to fall.




Just sneaking above the trend line, but need to be way above it to get it to change.

Here's the ISA and shares portfolio after week 10 of year 8.




Weekly Change
Cash £60.17

+£50.00
Portfolio cost £82,003.25
+£0
Portfolio sell value (bid price-commission) £29,692.49 (-63.8%) -£5.45
Potential profits £471.51
+£0
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.02
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£434.68 (-11.8%) +£46.49
Total Dividends £11,768.92
+£0
Total Interest £0.02
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £446.46
(12.1%) -£1.24
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

This account actually dropped by £5, but nothing else changed except me adding £50 to cover fees for a while.






Flat

The SIPP looks like this after week 358 overall and week 46 of year 7.




Weekly Change
Cash £77.16
-£230.99
Portfolio cost £96,196.55
+£249.94
Portfolio sell value
(bid price - commission)
£41,294.15 (-57.1%) +£163.75
Potential profits £585.01
+£72.45
Yr 7 Dividends £10,772.53
+£18.95
Yr 7 Interest £0.01
+£0
Yr 7 Profit from sales -£3,290.88
+£0
Yr 7 projected avg monthly profit £689.43 (14.5%) -£14.49
Total Dividends £13,976.92
+£18.95
Total Interest £0.21
+£0
Total Profit from sales £20,433.75
+£0
Average monthly cash profit £404.59 (8.5%) -£1.03
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 59% +0%

I spent my tax rebate on another 1,069 shares in PBX:Probiotix at 22.45p costing £249.94, portfolio value sneaked up £163 and potential profits also climbed £72. There was an £18.95 dividend from CEY:Centamin which was nice.




All looking pretty flat




What I wouldn't give to get above that trend line!

The trading account looks like this after week 324 overall and week 12 of year 7.




Weekly Change
Cash £0.10
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £658.85 (-64.4%) +£0
Potential profits £0.00
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£28.26 (-18.3%) +£2.36
Dividends £60.10
+£0
Interest £0.01
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.88 (1.9%) +£0
(Sold stocks profit + Dividends - Fees
/ Months)

There has never been a week this flat for the trading account






The last month feels like the calm before a storm - I just hope it's not a storm that takes my portfolio even lower. I desperately need to write about some good news for once.

Sunday 2 October 2022

Weeks 371-373 Review - Yet another record low while on holiday but it could have been much worse

I was away from Internet for 3 weeks so unable to take a weekly snapshot, but over the three weeks nearly everything fell in value to a new records low. Thankfully a small rise in PBX:Probiotix reduced the impact, and given the economic turmoil while I was away, I'm actually quite relieved the losses were not much bigger.

The deficit between cost and value widened by £838 to £108,561 and overall value dropped to £71,555. Generally a complete and utter disaster, and I'm really quite fed of writing that every week for well over a year.

EMG:Man Group was the biggest loser, falling 15% and going into loss. I don't really understand why, as I would have thought hedge funds can ride out these sorts of markets pretty well, but it appears the market doesn't agree.

BLU:Blue Star Capital dropped 8%, possibly because one of it's investments Guild eSports is having a spot of bother. I really don't care about that, as it's Satoshipay that will make or break this investment.

FXPO:Ferrexpo dropped 7% after a recent rally, presumably as the Ukrainian situation isn't getting any better.

SBTX:SkinBioTherapeutics fell 7% for no particular reason other than nothing has happened for ages and people are bored.

CAML:Central Asia Metals dropped 6% and has gone into loss, but this was partly due to going ex-dividend. I wish I had some cash to buy more but my pension transfer isn't going to hapen this month as it's been hammered and won't reach the £2,200 I need.

TRX:Tissue Regenix dropped 5%, which is disappointing as I thought this one had turned around.

Share of the (3) Week(s) is PBX:Probiotix Health, which is the only one to increase by 5% or more, rising 5% on anticipation of results. It was actually higher but fell when the actual results were posted.




There may have been more volatility over the last 3 weeks, but I don't know, so just made a gradual drop to where we are now so the timeline stays consistent.




At least we're back on the trend line, but if we don't go above it soon I'm going to run out of monay.

Here's the ISA and shares portfolio after week 9 of year 8.




Weekly Change
Cash £10.17

+£0.02
Portfolio cost £82,003.25
+£0
Portfolio sell value (bid price-commission) £29,697.94 (-63.8%) -£189.22
Potential profits £471.51
+£471.51
Yr 8 Dividends £0
+£0
Yr 8 Interest £0.02
+£0.02
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£481.17 (-13.0%) +£237.89
Total Dividends £11,768.92
+£0
Total Interest £0.02
+£0.02
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £447.70
(12.1%) -£3.68
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

Potential profits increased thanks to the rise in PBX:Probiotix, and I got 2p interest which was thrilling.




I had to lower the bottom of the axis, which is very sad.




The SIPP looks like this after week 357 overall and week 45 of year 7.




Weekly Change
Cash £308.15
+£266.48
Portfolio cost £95,946.61
+£122.47
Portfolio sell value
(bid price - commission)
£40,880.46 (-57.4%) -£636.91
Potential profits £512.56
+£452.44
Yr 7 Dividends £10,753.58
+£26.45
Yr 7 Interest £0.01
+£0
Yr 7 Profit from sales -£3,290.88
+£0
Yr 7 projected avg monthly profit £703.92 (14.8%) -£48.73
Total Dividends £13,957.97
+£26.45
Total Interest £0.21
+£0
Total Profit from sales £20,433.75
+£0
Average monthly cash profit £405.62 (8.5%) -£3.25
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 59% +0%

I got some tax rebates so cash up by £266, and my regular investment went on another 47 EMG:Man Group shares costing £122.47 just before their price plummeted. Potential profits up thanks to PBX:Probiotix, although thanks to the lock-in I can't sell them until January when the price will no doubt plummet as everyone sells. My plan is to sell my actual holding of these a few days before they can =be sold, so I can buy them back much cheaper when the price crashes. No doubt something will screw up my plans us usual.

The dividends were £16.44 from APAX:Apax Global Alpha and £10.01 from EMG:Man Group.






The trading account looks like this after week 323 overall and week 11 of year 7.




Weekly Change
Cash £0.10
+£0.01
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £658.85 (-64.4%) -£12.35
Potential profits £0.00
+£0
Year 7 Dividends £0.00
+£0
Year 7 Interests £0.01
+£0.01
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£28.26 (-18.3%) +£10.59
Dividends £60.10
+£0
Interest £0.01
+£0.01
Profit from sales £154.87
+£0
Average monthly cash profit £2.88 (1.9%) -£0.03
(Sold stocks profit + Dividends - Fees
/ Months)

Down yet again, but 1p interest - woohoo!





I had a nice holiday.

Week 370 Review- New record low but at least I was on holiday

Another record low as the deficit widens by another £1,916 to £107,723 and portfolio value drops to £72,005. Glad I was on holiday and missed it.

CAML:Central Asia Metals climbed 5% and is just about in profit, but Share of the Week goes to EMG:Man Group which also rose 5% but is 3% up overall.





Here's the ISA and shares portfolio after week 6 of year 8.




Weekly Change
Cash £10.15

+£0
Portfolio cost £82,003.25
+£0
Portfolio sell value (bid price-commission) £29,887.16 (-63.6%) -£1,031.88
Potential profits £0
+£0
Yr 8 Dividends £0
+£0
Yr 8 Profit from sales -£995.63
+£0
Yr 8 projected avg monthly profit -£719.06 (-19.5%) +£143.82
Total Dividends £11,768.92
+£0
Total Profit from sales £27,098.43
+£0
Average monthly cash profit £451.38
(12.2%) -£1.22
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 87% +0%

Nothing really happened other that OPTI:Optibiotix dropping yet again to chip away more of the portfolio value





The SIPP looks like this after week 354 overall and week 42 of year 7.




Weekly Change
Cash £41.68
+£0
Portfolio cost £95,824.14
+£0
Portfolio sell value
(bid price - commission)
£41,394.90 (-56.8%) -£860.28
Potential profits £60.12
+£23.48
Yr 7 Dividends £10,727.13
+£0
Yr 7 Interest £0.01
+£0
Yr 7 Profit from sales -£3,290.88
+£0
Yr 7 projected avg monthly profit £752.65 (15.9%) -£18.36
Total Dividends £13,931.52
+£0
Total Interest £0.21
+£0
Total Profit from sales £20,433.75
+£0
Average monthly cash profit £408.87 (8.6%) -£1.16
(Sold stocks profit + Dividends - Fees
/ Months)
Compound performance 59% +0%

Same here, but a huge £23 increase in potential profits to a whopping £60. I really don't know why I bother.





The trading account looks like this after week 320 overall and week 8 of year 7.




Weekly Change
Cash £0.09
+£0
Portfolio cost £1,849.21
+£0
Portfolio sell value (bid price - commission) £671.20 (-63.7%) -£24.69
Potential profits £0.00
+£0
Year 7 Dividends £0.00
+£0
Year 7 Profit -£71.73
+£0
Yr 7 projected avg monthly profit -£38.85 (-25.2%) +£5.55
Dividends £60.10
+£0
Profit from sales £154.87
+£0
Average monthly cash profit £2.91 (1.9%) -£0.01
(Sold stocks profit + Dividends - Fees
/ Months)


Down again - complete rubbish





No point in commenting as this is 4 weeks late and I was on holiday for the whole time - at least I had Internet and was able to take a snapshot. More than I can say for the next 3 weeks, but probably for the best